复苏性主动脉腔内球囊阻断与复苏性开胸在创伤性心脏骤停中结局相似
本研究为美国国防部资助的Emergent Truncal Hemorrhage Control研究的事先计划二次分析,2017至2018年在六家一级创伤中心开展前瞻性观察研究,纳入非可压迫性躯干出血患者,二次分析纳入72例创伤性心脏骤停患者(REBOA组26例,复苏性开胸组46例)。REBOA组年龄更大、体重指数更高、穿透伤比例更低,腹部损伤较轻而四肢损伤较重,总体损伤严重度评分相似。两组死亡率无显著差异(88% vs 93%,p=0.767),校正分析后仍相似(RR 0.89,95%CI 0.71-1.12,p=0.304)。但REBOA组主动脉阻断时间更长(7 vs 4分钟,p=0.001),急诊红细胞输注(4.5 vs 2.5单位,p=0.007)和血浆输注(3 vs 1单位,p=0.032)更多。作者认为需进一步研究以明确REBOA在创伤中的作用。
要点
- 创伤性心脏骤停患者中REBOA与复苏性开胸死亡率无显著差异(88% vs 93%,p=0.767),校正后RR 0.89(95%CI 0.71-1.12,p=0.304)。
- REBOA组主动脉阻断时间显著长于复苏性开胸组(7 vs 4分钟,p=0.001)。
- REBOA组急诊红细胞输注(4.5 vs 2.5单位,p=0.007)和血浆输注(3 vs 1单位,p=0.032)均多于复苏性开胸组。
- REBOA组患者年龄更大、体重指数更高、穿透伤比例更低,腹部损伤较轻而四肢损伤较重,总体损伤严重度评分相似。
- 作者认为需进一步研究以更好地界定REBOA在创伤中的作用。
适用人群与场景
- 美国六家一级创伤中心2017至2018年收治的非可压迫性躯干出血患者中,发生创伤性心脏骤停并接受REBOA或复苏性开胸者,共72例(REBOA组26例,复苏性开胸组46例)。
研究设计与关键结果
- 研究类型:美国国防部资助的Emergent Truncal Hemorrhage Control研究的事先计划二次分析,2017至2018年在六家一级创伤中心开展的前瞻性观察研究。
- 主研究共纳入454例患者,二次分析纳入72例创伤性心脏骤停患者,其中26例行REBOA,46例行复苏性开胸。
- REBOA组年龄更大、体重指数更高、穿透伤比例更低,腹部损伤较轻而四肢损伤较重,总体损伤严重度评分相似。
- 两组死亡率无显著差异(88% vs 93%,p=0.767)。
- REBOA组主动脉阻断时间更长(7 vs 4分钟,p=0.001)。
- REBOA组急诊红细胞输注更多(4.5 vs 2.5单位,p=0.007),血浆输注更多(3 vs 1单位,p=0.032)。
- 校正分析后两组死亡率仍相似(RR 0.89,95%CI 0.71-1.12,p=0.304)。
证据类型、等级与局限
- 证据类型:前瞻性观察研究的事先计划二次分析;证据等级:治疗/照护管理,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在创伤性心脏骤停患者中,REBOA与复苏性开胸的生存结局相似,但REBOA组主动脉阻断时间更长(7 vs 4分钟,p=0.001),且急诊红细胞和血浆输注需求更多。
- 作者认为需进一步研究以更好地界定REBOA在创伤中的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a minimally invasive alternative to resuscitative thoracotomy (RT) for patients with hemorrhagic shock. However, the potential benefits of this approach remain subject of debate. The aim of this study was to compare the outcomes of REBOA and RT for traumatic cardiac arrest.
METHODS: A planned secondary analysis of the United States Department of Defense-funded Emergent Truncal Hemorrhage Control study was performed. Between 2017 and 2018, a prospective observational study of noncompressible torso hemorrhage was conducted at six Level I trauma centers. Patients were dichotomized by REBOA or RT, and baseline characteristics and outcomes were compared between groups.
RESULTS: A total of 454 patients were enrolled in the primary study, of which 72 patients were included in the secondary analysis (26 underwent REBOA and 46 underwent resuscitative thoracotomy). Resuscitative endovascular balloon occlusion of the aorta patients were older, had a greater body mass index, and were less likely to be the victims of penetrating trauma. Resuscitative endovascular balloon occlusion of the aorta patients also had less severe abdominal injuries and more severe extremity injuries, although the overall injury severity scores were similar. There was no difference in mortality between groups (88% vs. 93%, p = 0.767). However, time to aortic occlusion was longer in REBOA patients (7 vs. 4 minutes, p = 0.001) and they required more transfusions of red blood cells (4.5 vs. 2.5 units, p = 0.007) and plasma (3 vs. 1 unit, p = 0.032) in the emergency department. After adjusted analysis, mortality remained similar between groups (RR, 0.89; 95% confidence interval, 0.71-1.12, p = 0.304).
CONCLUSION: Resuscitative endovascular balloon occlusion of the aorta and RT were associated with similar survival after traumatic cardiac arrest, although time to successful aortic occlusion was longer in the REBOA group. Further research is needed to better define the role of REBOA in trauma.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Koh EY, Fox EE, Wade CE, et al. Resuscitative endovascular balloon occlusion of the aorta and resuscitative thoracotomy are associated with similar outcomes in traumatic cardiac arrest. J Trauma Acute Care Surg. 2023. PMID: 37381147. doi:10.1097/TA.0000000000004094
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。